Randomized controlled trial2019

High-dose preoperative cholecalciferol to prevent post-thyroidectomy hypocalcaemia: A randomized, double-blinded placebo-controlled trial

Rowe CW, Arthurs S, O'Neill CJ, Hawthorne J, Carroll R, Wynne K, Bendinelli C

Clinical endocrinology · 15 citations

Review labels

Funding not disclosed

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Randomized controlled trial (indexed by PubMed)
Studied in
People
Main outcome
Clinical events such as disease or death

Who paid for it

Funding
Funding not disclosed

Publication

Published
2018-11-02 · Clin Endocrinol (Oxf) · vol. 90 · issue 2 · pp. 343–350
Publisher
Wiley
Cited
24 citations · more than 81% of similar papers · 1.3× the field average
References
20 works
Access
Paywalled
Research areas
Thyroid and Parathyroid Surgery · Parathyroid Disorders and Treatments · Uterine Myomas and Treatments
Keywords
Hypocalcaemia, Medicine, Cholecalciferol, Placebo, Thyroidectomy, Vitamin D and neurology, Internal medicine, Gastroenterology, vitamin D deficiency, Surgery, Endocrinology, Thyroid, Calcium, Pathology
MeSH
humans, hypocalcemia, cholecalciferol, treatment outcome, premedication, preoperative care, thyroidectomy, adult, middle aged, female, male, calcium-regulating hormones and agents

7 authors

From AU

  • Christopher W. RoweJohn Hunter Hospital; University of Newcastle Australia
  • Sam ArthursJohn Hunter Hospital
  • Christine J. O’NeillJohn Hunter Hospital; University of Newcastle Australia
  • Jacqueline HawthorneJohn Hunter Hospital
  • Rosemary CarrollJohn Hunter Hospital
  • Katie WynneJohn Hunter Hospital; University of Newcastle Australia

Abstract

Objective

Post-thyroidectomy hypocalcaemia is a significant cause of morbidity and prolonged hospitalization, usually due to transient parathyroid gland damage, treated with calcium and vitamin D supplementation. We present a randomized, double-blinded placebo-controlled trial of preoperative loading with high-dose cholecalciferol (300 000 IU) to reduce post-thyroidectomy hypocalcaemia.

Patients and measurements

Patients (n = 160) presenting for thyroidectomy at tertiary hospitals were randomized 1:1 to cholecalciferol (300 000 IU) or placebo 7 days prior to thyroidectomy. Ten patients withdrew prior to surgery. The primary outcome was post-operative hypocalcaemia (corrected calcium <2.1 mmol/L in first 180 days).

Results

The study included 150 patients undergoing thyroidectomy for Graves' disease (31%), malignancy (20%) and goitre (49%). Mean pre-enrolment vitamin D was 72 ± 26 nmol/L. Postoperative hypocalcaemia occurred in 21/72 (29%) assigned to cholecalciferol and 30/78 (38%) participants assigned to placebo (P = 0.23). There were no differences in secondary end-points between groups. In pre-specified stratification, baseline vitamin D status did not predict hypocalcaemia, although most individuals were vitamin D replete at baseline. Post-hoc stratification by day 1 parathyroid hormone (PTH) (<10 pg/mL, low vs ≥10 pg/mL, normal) was explored due to highly divergent rates of hypocalcaemia in these groups. Using a Cox regression model, the hazard ratio for hypocalcaemia in the cholecalciferol group was 0.56 (95%CI 0.32-0.98, P = 0.04) after stratification for Day 1 PTH. Further clinical benefits were observed in these subgroups.

Conclusions

Pre-thyroidectomy treatment with high-dose cholecalciferol did not reduce the overall rate of hypocalcaemia following thyroidectomy. In subgroups stratified by day 1 PTH status, improved clinical outcomes were noted.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.